Neil Diamond Announces Retirement from Concert Touring; Australian and New Zealand Tour Dates Cancelled
Legendary singer, songwriter and performer Neil Diamond today announced his retirement from touring due to his recent diagnosis of Parkinson’s disease. The onset of the disease has made it difficult to travel and perform on a large scale basis but will allow Mr. Diamond to continue his writing, recording and development of new projects. Based on his doctors’ advice, the third leg of Diamond’s 50th Anniversary tour, set to land in Australia and New Zealand this March, has been cancelled.
“It is with great reluctance and disappointment that I announce my retirement from concert touring. I have been so honored to bring my shows to the public for the past 50 years,” said Neil Diamond. “My sincerest apologies to everyone who purchased tickets and were planning to come to the upcoming shows.
I plan to remain active in writing, recording and other projects for a long time to come.
My thanks go out to my loyal and devoted audiences around the world. You will always have my appreciation for your support and encouragement. This ride has been ‘so good, so good, so good’ thanks to you.”
The Australia and New Zealand leg of the 50th Anniversary tour (announced by TEG Dainty in November, 2017) was scheduled to visit a number of outdoor stadiums as well as arena and winery shows in Australia and New Zealand. This would have been the third leg of the 50th Anniversary tour with Diamond selling out shows in the U.S. and Europe throughout 2017.
In making the announcement, Paul Dainty, President and CEO of TEG Dainty, stated: “I am devastated and saddened to hear the news of Neil’s illness and his retirement from touring. I have had the honour of promoting Neil’s numerous tours in Australia and New Zealand, he is one of the world’s greatest artists and we and his thousands and thousands of fans here will miss seeing him tour down under.”
On January 24th, Diamond will celebrate his 77th birthday and on January 28th The Recording Academy will honor him with its prestigious Lifetime Achievement Award.
Credit & Debit Card - Tickets purchased by credit or debit card will be refunded in full (including your ticket insurance premium, if relevant) and you do not need to take any action. Please allow up to 10 working days for the refund to appear in your account.
Cash & Eftpos - Patrons who purchased tickets with cash or EFTPOS, Ticketek will be in contact to arrange a refund.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Patient-Data Platform Raremark Raises £3m to Enable Precision Medicine in Rare Disease22.10.2018 15:00 | Tiedote
Raremark, the leading patient-data platform in rare disease, has raised £3m in funding from investors, led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund. The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments. Raremark’s platform is the foundation for building research networks of rare disease patients and their families. Raremark provides biopharmaceutical companies with access to anonymized and aggregated patient data, helping to reduce the time and cost of clinical development. The Raremark platform engages and retains patients, leveraging machine-learning technologies in novel ways. The approach is designed to raise health literacy and informed participation in medical research, to improve the quality of existing therapies and t
Celltrion Healthcare Hosts Forum with Patient Advocacy Groups to Provide Information on the Use of Biosimilars in Oncology22.10.2018 14:50 | Tiedote
To coincide with the ESMO 2018 Congress in Munich, Germany, Celltrion Healthcare invited perspective from experts including a physician and pharmacist to provide information to patient advocacy groups on the history of biosimilars, how they are tested and approved, their cost saving benefit and the wealth of clinical evidence already available on their use in order to improve understanding of biosimilars. The introduction of biosimilars in the treatment of cancer has the potential to reduce pressure on healthcare budgets and increase access to other innovative treatments or more potent regimens. This is achieved by offering more cost-effective alternatives to the reference medicinal products and by increasing competition in the market. Breast cancer is the most common cancer in women worldwide and accounts for a quarter of all cancer diagnoses in women.1 For the benefits of biosimilar use to be realised in oncology, and in the treatment of breast cancer, barriers to their uptake need t
Sony Corporation Selects ANAQUA for IP Management22.10.2018 14:00 | Tiedote
Anaqua, Inc., the leading provider of innovation and intellectual property (IP) management solutions, today announced that multinational technology company Sony Corporation has entered into a multi-year agreement to use the ANAQUA software to manage its patent and trademark portfolios. Sony is one of the world’s largest technology and entertainment companies, with products spanning consumer electronics, smart phones, game and network services, financial services, and professional products. “We are excited to welcome one of the world’s largest companies and IP leaders to Anaqua’s growing client community,” said Bob Romeo, CEO of Anaqua. “Sony’s decision to strategically partner with Anaqua for their IP Management system reinforces our continued investment in the APAC market.” ABOUT ANAQUA The most innovative companies in the world innovate with Anaqua. Its simplified software platform combines insight from big data analytics with critical tools, best practice workflows and advanced serv
Dentsu Aegis Network Announces the Acquisition of Namics AG22.10.2018 14:00 | Tiedote
Dentsu Aegis Network today announces that it has signed a definitive agreement to acquire Namics AG, a leading full-service digital agency in Switzerland and Germany. Following the acquisition, which is subject to approval from the German competition authority, the company will become ‘Namics - A Merkle Company’. Namics’ digital experience, creative and service design expertise complements Merkle’s already significant customer experience (CX) and marketing technology practice in the region. An important step in Merkle’s strategy to increase its global footprint, it provides further scale and depth to Merkle’s people-based marketing capabilities, in particular in the areas of business transformation strategy, digital consulting and technology implementation across Adobe Experience Cloud, Sitecore, Salesforce and SAP and other leading technology partners. All Namics‘ 550 digital specialists based in Frankfurt, Hamburg, Munich, St. Gallen, Zurich and Belgrade will join Merkle, bringing it
4th International Conference on the Economics of Happiness 2018 to Be Held in Jeonju22.10.2018 14:00 | Tiedote
The 4th International Conference on the Economics of Happiness 2018 Jeonju will be held on November 8~9, 2018 at the Korea Traditional Culture Center in Jeonju to explore solutions for happiness and better future of citizens. Jeonju is the most unique Korean city and a typical tourist destination in Asia that has successfully preserved Korean traditional culture. With participation by experts in human, ecosystemic and social economics as well as leaders in organizations and entrepreneurs, including Helena Norberg Hodge, President of Local Futures, the International Conference on the Economics of Happiness 2018 will feature lectures and discussions to share experiences and present a vision under the subtitle of the ‘Strategy for Localization’. Starting with a keynote address by President Hodge, Junko Edahiro, President of the Institute for Studies in Happiness, Economy and Society in Japan, Takahashi Hiromichi, CEO of PAL System, and Jay Tompt, Professor of Economics at University of Pl
E2open to Acquire INTTRA, Adding the World’s Leading Ocean Shipping Network and Software Provider, Creating an Integrated Global Supply Chain and Logistics Operating Network22.10.2018 13:00 | Tiedote
E2open, the one place in the cloud to run your supply chain, today announced the acquisition of INTTRA, the leading ocean shipping network, software and information provider. The combination of INTTRA’s ocean carrier and shipper network with E2open’s industry leading business network will create a unified global logistics and supply chain network. E2open and INTTRA will join efforts to strengthen the connections and streamline the information flow between manufacturers, suppliers, shipping service providers, ocean carriers and all the participants in global trade. E2open is the largest cloud-based provider of networked supply chain solutions, featuring a complete portfolio of applications that enable the world’s most complex supply chains to better plan, collaborate, and execute their end-to-end operations. More than 70,000 partner companies and 200,000 users, many of the biggest brands and manufacturers across a range of industries, use the E2open network and platform to orchestrate t
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme